OA02.05 CK-101 (RX518), a Third Generation Mutant-Selective Inhibitor of EGFR in NSCLC: Results of an Ongoing Phase I/II Trial von Johnson, M., Karlix, J., Burris, H., Jones, S., Harris, D., O'Byrne, K., Sriuranpong, V., Charoentum, C., Prasongsook, N., Jitpewngam, W., Wirasorn, K., Wang, J., Waqar, S., Oliviero, J., Gorelik, L., Qian, X.

Volltext